Adaptive Biotechnologies Corporation (ADPT) earnings
ADPT earnings moved a median of -1.47% by the close. Quarterly and annual ADPT reports and results, each read against the price at its own news timestamp. Back to the ADPT overview →
31 measured ADPT earnings events.
Where these ADPT earnings landedvs 31 measured ADPT earnings reactions
| Middle 50% of ADPT earnings reactions | -5.36% to +3.07% |
|---|---|
| Median reaction (to close) | -1.47% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 ADPT earnings events with a measured close landed between -5.36% and +3.07%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026 | Press release | -0.94% | +0.43% | |
| Form 10-Q Adaptive Biotechnologies For: Jun 30 | SEC filing · Form 10-Q | +0.28% | +0.24% | |
| Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results | Press release | +5.43% | +8.92% | |
| Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 | Press release | +0.20% | -3.92% | |
| Adaptive Biotechnologies Reports First Quarter 2026 Financial Results | Press release | +3.39% | +3.07% | |
| Form 10-Q Adaptive Biotechnologies For: Mar 31 | SEC filing · Form 10-Q | +3.39% | +3.07% | |
| Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 | Press release | -1.12% | -1.47% | |
| Form 10-K Adaptive Biotechnologies For: Dec 31 | SEC filing · Form 10-K | -0.43% | -1.29% | |
| Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results | Press release | -0.89% | -8.20% | |
| Form 10-Q Adaptive Biotechnologies For: Sep 30 | SEC filing · Form 10-Q | -0.89% | -8.20% | |
| Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | +1.81% | +0.94% | |
| Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results | Press release | -3.48% | -6.48% | |
| Form 10-Q Adaptive Biotechnologies For: Jun 30 | SEC filing · Form 10-Q | -3.48% | -6.48% | |
| Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025 | Press release | +0.00% | -2.69% | |
| Adaptive Biotechnologies Reports First Quarter 2025 Financial Results | Press release | +11.29% | +11.69% | |
| Form 10-Q Adaptive Biotechnologies For: Mar 31 | SEC filing · Form 10-Q | +11.29% | +11.69% | |
| Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 | Press release | -1.84% | +4.34% | |
| Form 10-K Adaptive Biotechnologies For: Dec 31 | SEC filing · Form 10-K | +0.19% | +4.64% | |
| Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results | Press release | +2.83% | -3.00% | |
| Form 10-Q Adaptive Biotechnologies For: Sep 30 | SEC filing · Form 10-Q | +2.83% | -3.00% | |
| Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 | Press release | -2.26% | +0.82% | |
| Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results | Press release | +4.38% | +4.62% | |
| Form 10-Q Adaptive Biotechnologies For: Jun 30 | SEC filing · Form 10-Q | +4.38% | +4.62% | |
| Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024 | Press release | -0.25% | +1.01% | |
| Adaptive Biotechnologies Reports First Quarter 2024 Financial Results | Press release | +10.71% | -5.36% | |
| Form 10-Q Adaptive Biotechnologies For: Mar 31 | SEC filing · Form 10-Q | +10.71% | -5.36% | |
| Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 | Press release | -3.47% | -4.69% | |
| Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue | Press release | -4.56% | -9.46% | |
| Form 10-K Adaptive Biotechnologies For: Dec 31 | SEC filing · Form 10-K | -1.70% | -1.95% | |
| Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | -3.73% | -6.40% | |
| Form 10-Q Adaptive Biotechnologies For: Sep 30 | SEC filing · Form 10-Q | -3.73% | -6.40% |
Keep exploring
More ADPT: analyst actions → · SEC filings → · ADPT overview →